Xanthoneantitumor, antihepatotoxic, anti-inflammatory and antimicrobial activities CAS# 90-47-1 |
2D Structure
- Vinblastine Sulfate
Catalog No.:BCN2292
CAS No.:143-67-9
- Pepstatin A
Catalog No.:BCC1218
CAS No.:26305-03-3
- Dexamethasone (DHAP)
Catalog No.:BCC1184
CAS No.:50-02-2
- Omeprazole
Catalog No.:BCC1254
CAS No.:73590-58-6
- E 64d
Catalog No.:BCC1127
CAS No.:88321-09-9
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 90-47-1 | SDF | Download SDF |
PubChem ID | 7020 | Appearance | Powder |
Formula | C13H8O2 | M.Wt | 196.2 |
Type of Compound | Xanthones | Storage | Desiccate at -20°C |
Solubility | Soluble to 39 mg/mL warmed (198.77 mM) in DMSO | ||
Chemical Name | xanthen-9-one | ||
SMILES | C1=CC=C2C(=C1)C(=O)C3=CC=CC=C3O2 | ||
Standard InChIKey | JNELGWHKGNBSMD-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C13H8O2/c14-13-9-5-1-3-7-11(9)15-12-8-4-2-6-10(12)13/h1-8H | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Xanthone has antioxidant and anticorrosive properties, it performed excellently as a corrosion inhibitor for mild steel in sulphuric acid solution. |
In vitro | Anti-corrosive properties of xanthone on mild steel corrosion in sulphuric acid: Experimental and theoretical investigations[Reference: WebLink]Current Applied Physics, 2011, 11(3):382-392.
|
In vivo | Bioavailability and antioxidant effects of a xanthone-rich Mangosteen (Garcinia mangostana) product in humans.[Pubmed: 19807152 ]J Agric Food Chem. 2009 Oct 14;57(19):8788-92Oxidative damage is involved in many chronic diseases including those cited as the major causes of death in Western societies such as cardiovascular disorders and cancer. Antioxidants may prevent these degenerative processes by various mechanisms including the scavenging of free radicals. Intake of antioxidant supplements is associated with preventing oxidative damages. |
Structure Identification | Revue Canadienne De Chimie, 1963, 41(2):522-526.Cook D . INFRARED SPECTRA OF XANTHONE: LEWIS ACID COMPLEXES.[Reference: WebLink]
|
Xanthone Dilution Calculator
Xanthone Molarity Calculator
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Xanthone shows the antagonism of endogenous nitric oxide synthase (NOS) inhibitors, it has antitumor, antihepatotoxic, anti-inflammatory and antimicrobial activities [1]. Two derivatives of xanthone potently inhibited nitric oxide synthesis with IC50 values of 4.3 and 4.4 μM, respectively [2].
In endothelial cells, NOS synthesizes nitric oxide (NO) from L-arginine. In the maintenance of vascular structure and tone, NO has been thought to play a key role [1].
Asymmetric dimethylarginine (ADMA) is synthesized by protein arginine methyltransferases (PRMTs), using S-adenosylmethionine as methyl group donor. Dimethylarginine dimethylaminohydrolase (DDAH) degrades ADMA to L-citrulline and dimethylamine. There are two different isoforms of DDAH, DDAH-1 and DDAH-2. Typically, DDAH-1 is found in tissues containing neuronal NOS, whereas DDAH-2 predominates in tissues expressing the endothelial isoform of NOS. In cultured endothelial cells, xanthones showed the inhibition of the upregulation of MCP-1 expression, the enhancement of monocytes adhesion and the increase in the release of LDH, concomitantly with the reduction of ADMA levels. These results suggest that xanthones protect against high-lipid-level-induced endothelial damage. This protective effect of xanthones is related to the reduction of ADMA concentration [1].
A single injection of native LDL caused a rapid accumulation and oxidation of LDL in the arterial wall. At 6 to 12 h after injection of LDL, ICAM-1 expression increased and led to endothelial dysfunction and an elevation of ADMA level. In vivo, pretreatment with xanthones attenuated the effect of the injection of LDL [1].
References:
[1]. Jiang DJ, Dai Z and Li YJ. Pharmacological effects of xanthones as cardiovascular protective agents. Cardiovasc Drug Rev, 2004, 22(2):91-102.
[2]. Boonnak N, Khamthip A, Karalai C, et al. Nitric Oxide Inhibitory Activity of Xanthones from the Green Fruits of Cratoxylum formosum ssp. pruniflorum. Australian Journal of Chemistry, 2010, 63(11):1550-1556.
- 4-Methylumbelliferone
Catalog No.:BCN2563
CAS No.:90-33-5
- Xanthoxylin
Catalog No.:BCN4443
CAS No.:90-24-4
- beta-Rhamnocitrin
Catalog No.:BCN3293
CAS No.:90-19-7
- 1-Naphthol
Catalog No.:BCC8473
CAS No.:90-15-3
- Guaiacol
Catalog No.:BCN8311
CAS No.:90-05-1
- Salicyl alcohol
Catalog No.:BCN4442
CAS No.:90-01-7
- 3-(Hydroxymethyl)-3-nitro-1-(4-octylphenyl)-1,4-butanediol
Catalog No.:BCN1313
CAS No.:899822-99-2
- 3-Nitro-1-(4-octylphenyl)-1-propanone
Catalog No.:BCN2250
CAS No.:899822-97-0
- CC-930
Catalog No.:BCC1459
CAS No.:899805-25-5
- ML 348
Catalog No.:BCC5611
CAS No.:899713-86-1
- A 438079
Catalog No.:BCC1316
CAS No.:899507-36-9
- Platycoside K
Catalog No.:BCN3242
CAS No.:899447-64-4
- 3,4,5-Trimethoxycinnamic acid
Catalog No.:BCN5030
CAS No.:90-50-6
- 6-Amino-4-hydroxy-2-naphthalenesulfonic acid
Catalog No.:BCC8761
CAS No.:90-51-7
- Lobelin
Catalog No.:BCN2157
CAS No.:90-69-7
- 4,4'-Bis(diethylamino)benzophenone
Catalog No.:BCC8659
CAS No.:90-93-7
- Boc-Ser(PO3Bzl2)-OH
Catalog No.:BCC3443
CAS No.:90013-45-9
- PIK-293
Catalog No.:BCC4994
CAS No.:900185-01-5
- PIK-294
Catalog No.:BCC4995
CAS No.:900185-02-6
- Agar (bacteriological)
Catalog No.:BCC1208
CAS No.:9002-18-0
- PFI 4
Catalog No.:BCC6484
CAS No.:900305-37-5
- Detomidine HCl
Catalog No.:BCC4346
CAS No.:90038-01-0
- Ylangenyl acetate
Catalog No.:BCN6704
CAS No.:90039-63-7
- Inulin
Catalog No.:BCC4789
CAS No.:9005-80-5
Benzophenones and xanthone derivatives from Garcinia schomburgkiana-induced P-glycoprotein overexpression in human colorectal Caco-2 cells via oxidative stress-mediated mechanisms.[Pubmed:28314481]
Phytomedicine. 2017 Apr 15;27:8-14.
BACKGROUND: Up-regulation of P-gp is an adaptive survival mechanism of cancer cells from chemotherapy. Three new phytochemicals including two benzophenones, guttiferone K (GK) and oblongifolin C (OC), and a Xanthone, isojacaruebin (ISO), are potential anti-cancer agents. However, the capability of these compounds to increase multidrug-resistance (MDR) through P-gp up-regulation in cancer cells has not been reported. PURPOSE: This study was to investigate the effects of GK, OC and ISO on P-gp up-regulation in colorectal adenocarcinoma cells (Caco-2 cells). In addition, the mechanisms underlying their inductive effect were also determined. METHODS: The inductive effect of GK, OC and ISO on P-gp expression at transcription level was measured by real-time reverse transcription polymerase chain reaction. The reactive oxygen species production was determined by 2', 7'-dichlorofluorescin diacetate assay. The protein content of P-gp and involvement of mitogen-activated protein kinases (MAPK) pathway was evaluated by western blot analysis. RESULTS: GK, OC and ISO (50 microM, 24 h) were able to increase the amount of MDR1 mRNA and protein in Caco-2 cells. The presence of N-acetyl-l-cysteine significantly prevented the inductive effect of GK, OC and ISO on MDR1 mRNA level. Moreover, MAPK inhibitors including U0126 (an ERK1/2/MAPK inhibitor) and SB202190 (p38/MAPK inhibitor) suppressed an increase of MDR1 mRNA levels in the cells treated with benzophenones (GK, OC) and Xanthone ISO, respectively. These findings were in agreement with the increase of phosphorylated form of either ERK1/2 (p-ERK1/2) or p38 (p-p38) upon treatment of the cells with these three compounds. In addition, OC and ISO, but not GK, increased mRNA of c-Jun level. CONCLUSION: The benzophenones GK, OC and Xanthone ISO are likely MDR inducers through up-regulation of P-gp expression at transcription level. Their molecular mechanisms involve oxidative stress-mediated activation of MAPK signaling pathway.
Large-Scale Preparation of a Specific Xanthone from Swertia mussotii and Evaluation of Its alpha-Glucosidase Inhibitory Activity.[Pubmed:28334929]
J Chromatogr Sci. 2017 Jul 1;55(6):638-644.
Large-scale preparation and alpha-glucosidase inhibitory activity of a specific Xanthone swertioside from Swertia mussotii were investigated in this study. Firstly, an efficient method was successfully established by liquid-liquid extraction, preparative high-performance liquid chromatography and sephadex LH-20 for large-scale preparation of swertioside. The recovery of swertioside reached 92.0%. Secondly, in vitro alpha-glucosidase inhibition experiment showed that swertioside had good inhibition close to acarbose. The study showed that swertioside had potential use as an anti-diabetic agent.
Penixanthones A and B, two new xanthone derivatives from fungus Penicillium sp. SYFz-1 derived of mangrove soil sample.[Pubmed:28299980]
Nat Prod Res. 2017 Oct;31(19):2218-2222.
Two new Xanthone derivatives, peniXanthones A (1) and B (2), together with three known compounds, aspenicillide (3), 1,5-dihydroxy-3-methoxy-7-methyl-anthracene-9,10-dione (4) and 1,2-indandiol (5), were isolated from the ethyl acetate extract of a culture of the fungus Penicillium sp. SYFz-1, which was separated from a mangrove soil sample. The structures of these compounds were elucidated by spectroscopic methods including NMR and mass spectrometry. The absolute configurations of peniXanthones A (1) and B (2) were determined on the basis of electronic circular dichroism (ECD) data analysis.
Synthesis of xanthone derivatives and studies on the inhibition against cancer cells growth and synergistic combinations of them.[Pubmed:28376372]
Eur J Med Chem. 2017 Jun 16;133:50-61.
34 Xanthones were synthesized by microwave assisted technique. Their in vitro inhibition activities against five cell lines growth were evaluated. The SAR has been thoroughly discussed. 7-Bromo-1,3-dihydroxy-9H-xanthen-9-one (3-1) was confirmed as the most active agent against MDA-MB-231 cell line growth with an IC50 of 0.46 +/- 0.03 muM. Combination of 3-1 and 5,6-dimethylXanthone-4-acetic acid (DMXAA) showed the best synergistic effect. Apoptosis analysis indicated different contributions of early/late apoptosis and necrosis to cell death for both monomers and the combination. Western Blot implied that the combination regulated p53/MDM2 to a better healthy state. Furthermore, 3-1 and DMXAA arrested more cells on G2/M phase; while the combination arrested more cells on S phase. All the evidences support that the 3-1/DMXAA combination is a better anti-cancer therapy.